Literature DB >> 11849201

Statins and the risk of idiopathic venous thromboembolism.

Chen-Chang Yang1, Susan S Jick, Hershel Jick.   

Abstract

AIMS: To evaluate the association between current statin use and the risk of idiopathic venous thromboembolism (VTE).
METHODS: A population-based retrospective follow-up with a nested case-control analysis using the General Practice Research Database.
RESULTS: There were 72 cases of idiopathic VTE. Using normolipidaemic nonuse as the reference group, the adjusted relative risks for idiopathic VTE for current/recent statin use, past statin use, past other lipid-lowering drug use, and hyperlipidaemic nonuse were 0.8 (0.3, 2.7), 2.4 (0.6, 10.0), 1.8 (0.4, 7.4), and 0.9 (0.4, 2.0) in the follow-up analysis, and were 1.1 (0.3, 4.3), 3.7 (0.6, 24.1), 2.0 (0.3, 11.6), and 0.4 (0.2, 1.2) in the case-control analysis.
CONCLUSIONS: Current statin use was not associated with a reduced risk of idiopathic VTE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849201      PMCID: PMC1874555          DOI: 10.1046/j.0306-5251.2001.01523.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Hemostatic effects of smoking and oral contraceptive use.

Authors:  F Fruzzetti
Journal:  Am J Obstet Gynecol       Date:  1999-06       Impact factor: 8.661

2.  A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

Authors:  F A Anderson; H B Wheeler; R J Goldberg; D W Hosmer; N A Patwardhan; B Jovanovic; A Forcier; J E Dalen
Journal:  Arch Intern Med       Date:  1991-05

3.  Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.

Authors:  H Jick; S S Jick; L E Derby
Journal:  BMJ       Date:  1991-03-30

4.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

5.  The risk of venous thromboembolism in users of postcoital contraceptive pills.

Authors:  C Vasilakis; S S Jick; H Jick
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

6.  Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

Authors:  D Grady; N K Wenger; D Herrington; S Khan; C Furberg; D Hunninghake; E Vittinghoff; S Hulley
Journal:  Ann Intern Med       Date:  2000-05-02       Impact factor: 25.391

7.  Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis.

Authors:  H Jick; J A Kaye; C Vasilakis-Scaramozza; S S Jick
Journal:  BMJ       Date:  2000-11-11

8.  Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.

Authors:  S Pérez Gutthann; L A García Rodríguez; J Castellsague; A Duque Oliart
Journal:  BMJ       Date:  1997-03-15

9.  Pulmonary artery atherosclerosis: correlation with systemic atherosclerosis and hypertensive pulmonary vascular disease.

Authors:  G W Moore; R R Smith; G M Hutchins
Journal:  Arch Pathol Lab Med       Date:  1982-08       Impact factor: 5.534

10.  Tamoxifen and risk of idiopathic venous thromboembolism.

Authors:  C R Meier; H Jick
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

View more
  16 in total

1.  Statins and the risk of idiopathic venous thromboembolism.

Authors:  Joel G Ray; Muhammad M Mamdani
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

2.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Sources of tissue factor that contribute to thrombosis after rupture of an atherosclerotic plaque.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Res       Date:  2012-03-22       Impact factor: 3.944

4.  Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

Authors:  Aneel A Ashrani; Michel K Barsoum; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2015-04-11       Impact factor: 3.944

5.  Statins, aspirin and risk of venous thromboembolic events in breast cancer patients.

Authors:  Ayelet Shai; Hedy S Rennert; Ofer Lavie; Muona Ballan-Haj; Arie Bitterman; Mariana Steiner; Shoshana Keren; Gad Rennert
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

6.  A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

Authors:  Robert J Glynn; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Paul M Ridker
Journal:  N Engl J Med       Date:  2009-03-29       Impact factor: 91.245

7.  Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation.

Authors:  Chen-Chang Yang; Susan S Jick; Marcia A Testa
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

8.  Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database.

Authors:  Corri Black; James A Kaye; Hershel Jick
Journal:  BMJ       Date:  2002-08-24

9.  Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials.

Authors:  Liam Smeeth; Ian Douglas; Andrew J Hall; Richard Hubbard; Stephen Evans
Journal:  Br J Clin Pharmacol       Date:  2008-11-05       Impact factor: 4.335

Review 10.  Validation and validity of diagnoses in the General Practice Research Database: a systematic review.

Authors:  Emily Herrett; Sara L Thomas; W Marieke Schoonen; Liam Smeeth; Andrew J Hall
Journal:  Br J Clin Pharmacol       Date:  2010-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.